52
CoRegen, Inc. raises $13.5M under Reg D
Company raise · Closed · Offering $13.5M · Sold $13.5M · HOUSTON, TX · filed 2026-02-26
Placement agent engaged
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Lee J. Fleisher, M.D. | Director |
| John Thomas, Jr. | Chief Financial Officer and Secretary of Issuer |
| Jonathan W. Simons | Director |
| William J. Haseltine, PhD. | Director |
| Edward J. Benz, Jr. | Director |
| David Lonard, PhD | Chief Science Officer of the Issuer |
| Suneet J. Varma | Director |
| Steve Gorlin | President of the Issuer |
| Clifford C. Dasco, M.D. | Chief Medical Officer of the Issuer |
| Bert W. O'Malley | Director |
Signed by John C. Thomas Jr., Chief Financial Officer of the Issuer.
Placement agents / sales compensation: M M Dillon & Co. LLC; M M Dillion & Co. LLC
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.